DMS INTEND TO AWARD RESEARCH INTO A RANDOMISED CONTROLLED TRIAL OF VOLATILE ANAESTHETIC AGENTS WITH INTRAVENOUS SEDATION IN TRAUMATIC BRAIN INJURY (TBI)

CPV: Laboratory services · Research laboratory services · Research services

Procedure method

Award procedure without prior publication of a call for competition

Legal basis

CELEX · 32009L0081 Defence and Security Public Contracts Regulations 2011 (Directive 2009/81/EC)

Procurement category

Services

Notice status

Awarded without competition

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Stand-alone contract (no framework)

Competition type

Direct award (no call for competition)

GPA / WTO covered

Unspecified in notice

Recurring procurement

Unspecified in notice

First published

30 May 2023, 09:28 BST

Last source update

30 May 2023, 09:28 BST

FTS notice number

2023/S 000-015212

Classification (CPV)

Laboratory servicesResearch laboratory servicesResearch services

Delivery area

UK

Official registry OCID

ocds-h6vhtk-03d01d Find a Tender

Why no open competition

The procurement falls outside the scope of application of the directive

Published justification

Defence Medical Services intend to award the Intravenous Sedation in Traumatic Brain Injury Contract, otherwise known as TBI, single source contract with an NHS University Teaching Hospital (UHNM). This is required for completion of PHD study as the student is based in this specific site and cannot conduct this research at another site.

The student cannot complete there study outside of the university, nor have they expressed any interest to do so, as this would cancel the progress made towards there PhD.

Publisher note: It is considered that this contract can be placed using the single source procedure without prior publication of a contract notice as permitted by Regulation 14 of the Public Contract Regulations 2015, exempting public sector Contracts for research and development services. Volatile anaesthetic agents are already widely used in human practice, including for anaesthesia for patients with brain injury requiring neurosurgery. They may reduce the activity of a known pathway of abnormal brain cell death and therefore have a neuroprotective effect. There have been no randomised controlled trials comparing volatile anaesthetic sedation against standard intravenous sedation for Traumatic Brain Injury (TBI) requiring critical care. Therefore, this study will be the first randomised controlled trial examining a novel neuroprotective strategy involving agents which are already widely available and in use in human medicine. If a benefit is shown and use of an inhaled sedation technique reduces mortality or morbidity from severe TBI, then this will be a clear clinical benefit to service personnel at risk of suffering from a TBI, and from a wider Defence perspective, if effective as a strategy to reduce the severity of traumatic brain injury, this will reduce the burden of death from TBI on operations or exercises, and the rehabilitation requirement and loss of troops to downgrading and medical discharge as the result of severe TBI.

• Royal Stoke University HospitalAwarded supplier Newcastle Road, Stoke-On-Trent, ST4 6QG, Stoke-On-Tren, UK, ST4 6QG

No document links were published on the notice.